Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 1 of 1 entries
Sorted by: Best Match Show Resources per page
Impact of oral soluble guanylate cyclase stimulators in heart failure: A systematic review and Meta-analysis of randomized controlled trials.

American heart journal

Moghaddam N, Malhi N, Toma M.
PMID: 34283990
Am Heart J. 2021 Nov;241:74-82. doi: 10.1016/j.ahj.2021.07.003. Epub 2021 Jul 18.

BACKGROUND: Soluble guanylate cyclase (sGC) stimulators are a novel class of medications with emerging role in heart failure (HF). The aim of this study is to evaluate the efficacy and safety of oral sGC stimulators in patients with HF...

Cite
Moghaddam N, Malhi N, Toma M. Impact of oral soluble guanylate cyclase stimulators in heart failure: A systematic review and Meta-analysis of randomized controlled trials. Am Heart J. 2021;241:74-82doi: 10.1016/j.ahj.2021.07.003.
Moghaddam, N., Malhi, N., & Toma, M. (2021). Impact of oral soluble guanylate cyclase stimulators in heart failure: A systematic review and Meta-analysis of randomized controlled trials. American heart journal, 24174-82. https://doi.org/10.1016/j.ahj.2021.07.003
Moghaddam, Nima, et al. "Impact of oral soluble guanylate cyclase stimulators in heart failure: A systematic review and Meta-analysis of randomized controlled trials." American heart journal vol. 241 (2021): 74-82. doi: https://doi.org/10.1016/j.ahj.2021.07.003
Moghaddam N, Malhi N, Toma M. Impact of oral soluble guanylate cyclase stimulators in heart failure: A systematic review and Meta-analysis of randomized controlled trials. Am Heart J. 2021 Nov;241:74-82. doi: 10.1016/j.ahj.2021.07.003. Epub 2021 Jul 18. PMID: 34283990.
Copy Download .nbib Format: NLM
Showing 1 to 1 of 1 entries